Trial Profile
A Pilot Study to Evaluate the Efficacy of Cetuximab Alone or in Combination with Chemotherapy or Radiotherapy in Patients with Locally Advanced, Inoperable Cutaneous Squamous Cell Carcinoma (CSCC).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 30 Nov 2015 New trial record